Hochschulschrift
Cyclooxygenase-2 blockade can improve the efficacy of VEGF-targeting drugs
- Alternative title
-
Cyclooxygenase-2 Blockierung kann die Wirksamkeit von VEGF-gerichteten Therapien verbessern
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Hamburg, Universität Hamburg, Dissertation, 2016
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Hamburg
- (who)
-
Staats- und Universitätsbibliothek Hamburg
- (when)
-
2016
- Creator
-
Cubas Córdova, Miguel
- Contributor
- URN
-
urn:nbn:de:gbv:18-80447
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Cubas Córdova, Miguel
- Loges, Sonja
- Staats- und Universitätsbibliothek Hamburg
Time of origin
- 2016
Other Objects (12)
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Untersuchung der Expression von Cyclooxygenase-2, VEGF und der Gefäßdichte im Nierenzellkarzinom
Monitoring nanoparticle tumor targeting to predict nanotherapy efficacy
Flipped classroom frameworks improve efficacy in undergraduate practical courses
Means and measures to improve treatment efficacy in pancreatic cancer
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Manipulating the metabolism to improve the efficacy of CAR T-cell immunotherapy
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Cancer drugs targeting DNA replication: Molecular strategies to enhance specificity and efficacy
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen
The pursuit of simplicity : Can simplifying eligibility criteria improve social pension targeting?
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Untersuchung der Expression von Cyclooxygenase-2, VEGF und der Gefäßdichte im Nierenzellkarzinom
Monitoring nanoparticle tumor targeting to predict nanotherapy efficacy
Flipped classroom frameworks improve efficacy in undergraduate practical courses
Means and measures to improve treatment efficacy in pancreatic cancer
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Manipulating the metabolism to improve the efficacy of CAR T-cell immunotherapy
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Cancer drugs targeting DNA replication: Molecular strategies to enhance specificity and efficacy
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen
The pursuit of simplicity : Can simplifying eligibility criteria improve social pension targeting?
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Untersuchung der Expression von Cyclooxygenase-2, VEGF und der Gefäßdichte im Nierenzellkarzinom
Monitoring nanoparticle tumor targeting to predict nanotherapy efficacy
Flipped classroom frameworks improve efficacy in undergraduate practical courses
Means and measures to improve treatment efficacy in pancreatic cancer
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Manipulating the metabolism to improve the efficacy of CAR T-cell immunotherapy
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Cancer drugs targeting DNA replication: Molecular strategies to enhance specificity and efficacy
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen
Analyse von VEGF, VEGF-Aktivierung und VEGF-Rezeptorexpression bei humanen entzündlichen Nierenerkrankungen